Pfizer Ltd

AGM Details

• AGM held on July 28, 2026 at 3:00 p.m. IST via VC/OAVM, concluded 5:17 p.m.
• Chair: Pradip Shah chaired from the registered office.
• Meeting conducted through VC/OAVM per MCA/SEBI circulars.
• Remote e-voting facility provided; Scrutinizer appointed for e-voting.

Key Resolutions

• Adopt Audited Financial Statements for the year ended March 31, 2026.
• Re-appoint P. Rengan as Director liable to retire by rotation.
• Ratify remuneration payable to Kishore Bhatia & Associates, Cost Accountants, for FY 2027.

Dividend

• Dividend of Rs 75 per equity share proposed under Ordinary Resolution.

Voting Results

• Voting results to be declared within 2 working days after the meeting.

Financial results approved

• Unaudited standalone Q1 FY2026-27 results approved: total income Rs 698.01 crore, net profit Rs 204.47 crore.

Regulatory and audit updates

• Limited Review Report on the quarter ended 30 June 2026 issued; no modifications.
• Audit Committee reviewed results prior to Board approval.

Key disclosures

• Board approved results on 28 July 2026.
• Single Pharmaceuticals segment; no additional segment disclosure.
• Exceptional items for year ended 31 Mar 2026: ₹49.16 crore, severance under Cipla deal.
• Labour Code changes increased employee benefit provisions by ₹7.43 crore for year ended 31 Mar 2026.
• No subsidiaries/associates/joint ventures as of 30 Jun 2026.

Resignation and Board Exit

• Amit Agarwal resigns as ED - Finance & CFO to pursue an external opportunity, effective Oct 8, 2026.
• Cease to be Director on the Board from Oct 8, 2026.
• Relinquish CSR, Risk Mgmt, Admin & Share Transfer Committee memberships effective Oct 8, 2026.

Meeting Details

• Board meeting scheduled for July 28, 2026; time and venue not disclosed.

Key Agenda Items

• To consider, approve and record the unaudited financial results for the quarter ended June 30, 2026.

Other Notes

• Trading window remains closed from June 30, 2026 to 48 hours after results disclosure on July 28, 2026.

Product availability update

• Premarin vaginal cream, an imported product, is temporarily discontinued in India due to supply constraints.
• Contributes less than 1% to Pfizer Limited's revenue; no material impact expected on financials or operations.
• Company exploring options to restore supply and return to normal availability.
• Not considered a material event requiring disclosure under SEBI LODR Regulation 30.

Compliance status

• Certificate confirms Regulation 74(5) compliance for the reporting quarter.

Annual report access and AGM details

• AGM date: July 28, 2026 at 3:00 PM IST via VC/OAVM.
• Annual Report FY2025-26 and Notice emailed to registered addresses on July 6, 2026.
• AR available at pfizerltd.co.in and on BSE/NSE and KFin e-voting portals.

Dividend and e-voting timelines

• Final dividend Rs 75 per equity share; record date July 17, 2026.
• E-voting/AGM cutoff: July 21, 2026; remote voting July 24–27, 2026.
• Dividend payment date: on or after August 4, 2026.
• Email/mobile registration is mandatory for e-voting and AGM participation.
• DP/ISR updates: Demat holders to update details; physical holders ISR-1/ISR-2 with RTA.
• RTA contact: KFin Technologies Limited; einward.ris@kfintech.com.